Reckitt Benckiser: UBS says buy ahead of business update

(CercleFinance.com) - UBS has confirmed its 'buy' recommendation and target price of 7170 pence (representing a 62% upside potential for the stock) on Reckitt Benckiser, anticipating sequentially better operating momentum in Q1.


The broker expects the British group to post flat LFL sales growth in Q1, with growth of nearly 3% in hygiene and health, offset by a 14% decline in nutrition.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.